Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01461876 · ClinicalTrials.gov registry record
Obesity in HIV After Antiretroviral Therapy
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 200
- Enrollment target
NCT01461876: Completed study, sponsored by Duke University.
NCT01461876 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01461876 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
This is a retrospective longitudinal study that evaluates the prevalence and incidence of overweight/obesity within an HIV-infected population before and after 12 and 24 months of a stable antiretroviral therapy (ART). The study group will be compared to the weight of a healthy, matched population that is not infected with HIV. The primary hypothesis states that the proportion of HIV-infected persons newly classified as overweight/obese will increase by ≥20% after 12 months of initial ART, and this incidence will be greater than that of a matched HIV-uninfected control population. The effect of immune function variables, such as CD4, HIV viral load, and ART regimen on weight will be analyzed. In addition, the study will analyze the effect of weight and immune function markers on the inflammatory markers, high sensitivity C-reactive protein (hsCRP) and D-dimer. An HIV samples repository will be used for specimens to be assayed for hsCRP and D-dimer.
Interventions
- DRUG antiretroviral therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2009-11 |
| Est. Completion | 2014-05 |
What the finished NCT01461876 record still lists
NCT01461876 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which antiretroviral therapy is the first listed.
NCT01461876 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01461876 about?
NCT01461876 is a clinical study titled "Obesity in HIV After Antiretroviral Therapy". This is a retrospective longitudinal study that evaluates the prevalence and incidence of overweight/obesity within an HIV-infected population before and after 12 and 24 months of a stable antiretroviral therapy (ART). The study group will be compared to the weight of a healthy, matched population t...
What is the current status of trial NCT01461876?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2009-11. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01461876?
The interventions under investigation include: antiretroviral therapy (DRUG).
Who is sponsoring clinical trial NCT01461876?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia